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Christian F. Poets, MD and Margit Bacher, MDobin sequence (RS) was first delineated by Fairbairn
in 1846 and Shukowsky in 19111,2; it was more for-
mally investigated by the French stomatologist Pierre
Robin in 1934, who later became the source of the eponym
for this condition.3 Robin described it as consisting of a hypo-
plastic or retropositioned mandible and glossoptosis, result-
ing in respiratory distress, with or without a cleft palate. It
fulfills criteria for a sequence, in which one or all anomalies
found are secondary to another anomaly.4 The incidence
varies between one in 8500 and one in 14 000 live births.5,6
The main functional problems associated with RS are
upper airway obstruction (UAO) and failure to thrive (the
latter resulting from feeding problems, UAO alone, or both
problems).6 Feeding problems are often long-lasting, result-
ing in gastrostomy rates of 50% in large series.7 Interventions
for RS should thus be assessed by their ability to improve pol-
ysomnography (PSG) results and weight gain. Although
reported as used in infants with RS by 74% of US pediatric
otolaryngology fellowship programs in 1994, only 39%
believed PSG to be indicated for most patients with this con-
dition, and just one in 5 performed serial PSG to test for
treatment effectiveness.8 However, it is difficult to document
the effect of treatments for RS on UAO without performing
PSG, especially because anatomy does not correlate well
with function.9
For this Medical Progress article, we searched PubMed for
studies on the effectiveness of interventions suggested to
improve UAO and weight gain in infants with RS (Table).
It does not cover surgical techniques for which evidence in
the literature is extremely scant or objective documentation
of their effectiveness lacking.
Procedures Aimed at Widening the
Pharyngeal Space
Prone Positioning
Prone positioning is based on the hypothesis originally pro-
posed by Robin3 that the narrow pharyngeal space in RS can
be corrected by the effect of gravity moving the mandible for-
ward in infants sleeping prone. In some case series, 50% to
80% of patients with RS were reported as having been suffi-
ciently treated with positioning only,10,11 but none of theseAHI Apnea-hypopnea index
MOAI Mixed-obstructive apnea index
PEBP Pre-epiglottic baton plate
PSG Polysomnography
RS Robin sequence
UAO Upper airway obstructionstudies documented its effectiveness objectively. It has been
suggested that the main reason why the prone position
appears effective is that the visual cues to UAO (paradoxical
chest movements or a pectus excavatum) are less visible in
this position.4 Moreover, it is questionable whether prone
positioning alone is sufficient to induce mandibular catch-
up growth.12 Most concerning, however, is that the prone
sleep position is associated with a more than 10-fold increase
in the risk of sudden infant death syndrome, making it ques-
tionable whether parents can safely be advised to place their
baby with RS prone for sleep.
Tongue-Lip Adhesion or Glossopexy
This idea on how to widen the pharyngeal space was first pro-
posed by Shukowsky2 and subsequently reported to result in
better survival rates.13 Success rates for this intervention, on
the basis of clinical criteria, vary.11 Except for the aforemen-
tioned study in 1946,13 we found one study of 48 infants with
RS that reported a non-significant increase in weight gain in
a mean duration of 1.4 years after tongue-lip adhesion (ie,
mean weight increased from the 9.7th to the 17.5th percen-
tile).14 Another study documented significant UAO in PSG
in 6 infants with RS and reported that a follow-up study after
tongue-lip adhesion, performed in5 infants before hospitaldis-
charge, demonstrated resolution of significant airway obstruc-
tion15; more detailed data were not provided. A recent case
series reported improved PSG results in 5 of 8 patients studied
after tongue-lip adhesion (of a total group of 22 patients) and
an unspecified degree of catch-up growth in 10 patients.16
In another follow-up study, however, 10 of 11 patients
with RS required additional interventions for airway or feed-
ing problems subsequent to tongue-lip adhesion.17 More-
over, complications such as wound infection, adhesion
dehiscence, and scar formation have been reported to occur
in approximately one in 5 to one in 4 patients.11,14 We there-
fore question whether tongue-lip adhesion can be recom-
mended as a ‘‘good surgical treatment for most children’’
with RS.16
Mandibular Distraction Osteogenesis
This procedure aims to correct the mandibular hypoplasia in
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THE JOURNAL OF PEDIATRICS  www.jpeds.com Vol. 159, No. 6and placing pins for a multi-vector external (or internal) dis-
tractor.
Beginning a few days after the operation, distraction is
usually done at a rate of 1 to 2 mm daily18 until the patient
has a class III occlusion. This over-correction is considered
necessary to sustain an adequate airway in case a (partial)
relapse occurs after distraction.19 The devices are usually
removed 4 to 8 weeks after the end of the distraction period.
Recently, the successful use of an internal single-stage self-
resorbable device also has been reported.20
Despite many studies reporting clinical success with this
technique, few of them reported changes in weight gain.
One study of 10 patients reported a decline in growth rate
in 7 patients in the first 12 months after mandibular distrac-
tion, despite continued tube feeding in 3 patients.21 This may
be related to dysphagia, often seen in RS, not being corrected
by the distraction procedure.22 In contrast, a study in 17
infants reported accomplishment of full oral feeding in all
infants by 3.5 months postoperatively, but provided no
growth data.23
Several case series reported PSG results before and after
mandibular distraction.18,22-26 All noted an improved or nor-
malized apnea-hypopnea index (AHI) or respiratory distur-
bance index in most patients studied, but only 3 series
provided detailed PSG results. One of the latter studies
included 7 patients and reported a decrease in AHI from 60
(SD, 7.3) before distraction to 1.6 (SD, 1.6) at the end of the
expander activation.18 No long-term follow-up data were
reported. Another study reported a decrease in mean AHI
from 10.6 (range, 0-43) to 2.2 (range, 0-12.9) in 13 infants
undergoing distraction osteogenesis,23 and the third and larg-
est study reported a decrease in AHI from a mean of 39.7
(range, 4.5-177.0) to 5.8 (range, 0-34) in a chart review of 28
infants in whom the procedure was performed and its effect
documented with PSG.26 The authors describing the self-
resorbable device aforementioned also reported resolution of
UAO(ie, an respiratory disturbance index<2.0) in all 9 of their
14 patients who did not undergo tracheostomy and who were
stable enough to tolerate a preoperative sleep study.20
Complications include scarring (sometimes hypertro-
phic), pin site infections (18%), device failure (10%), persis-
tent inferior alveolar nerve lesions (6%) and, somewhat more
rarely, damage to tooth buds resulting in long-term tooth
loss, dentigerous cyst formation, or relapse of UAO symp-
toms and temporo-mandibular ankylosis.27 Some of these
complications should be preventable with the new internal
resorbable devices, but more data are necessary.20
Mandibular Traction
This procedure, first described in 1937,28 involves fixation of
a percutaneous parasymphysial circumferential wire to the
mandible, with traction being applied with suspension
weights (50-200 g) left in place for 4 to 6 weeks. Its effect
on UAO is unknown, and it requires long-term immobiliza-
tion of the patient during a critical developmental period.
Also, a long-term follow-up study showed persistence of ret-
rognathia on cephalometric radiography.29888Procedures that Bridge the Narrow Upper
Airway
Nasopharyngeal Airway
This device, first suggested by a British group,30 bridges the
narrow pharyngeal space by inserting an endotracheal tube
in one of the nares so that it ends just superior to the epiglot-
tis (controlled with endoscopy or radiography). Methods of
estimating the required length of the tube without endoscopy
or radiography and securing it safely to the nose have been
described.31 One study reported on 22 infants with RS (3 syn-
dromic), with 20 being treated with a nasopharyngeal airway
and high-calorie nasogastric tube feeding. Infants were grad-
ually weaned from both tubes while being monitored for
oxygen saturation. During a mean duration of hospital stay
of 60 days (range, 25-162 days), 18 infants were reported to
grow along the percentile of their birth weight, but only 3
were fully bottle fed at discharge. Also, only 10 infants main-
tained their weight percentile until the time of cleft repair.
Unfortunately, no oximetry data were provided.32 Another
study reported weight gain in 8 infants with a nasopharyngeal
airway (median age, 50 days; range, 15-180 days; 4 also had
supplemental oxygen administered). Their weekly weight
gain increased from 86 g before to 255 g with the nasopharyn-
geal airway, but no data on weight gain after hospital dis-
charge or any PSG results were reported.33
Complications include blockage of the tube by secretions
and aspiration of gastric contents potentially occurring
when the airway is too long.32 Moreover, it provides no stim-
ulus for the mandible to grow or the tongue to assume amore
horizontal position. Although certainly valuable as a tempo-
rary measure, it does not solve the anatomical problems
underlying the UAO and poor weight gain.Pneumatic Airway Stenting with Nasal Continuous
Positive Airway Pressure or Intermittent Positive
Pressure Ventilation
There are some case series on the use of nasal continuous pos-
itive airway pressure or intermittent positive pressure venti-
lation in RS.34,35 In a recent single-center analysis of 81
patients with RS, 7 (9%) had been treated with nasal inter-
mittent positive pressure ventilation, starting at a mean age
of 2 months and lasting for a mean of 16.7 months. Reported
benefits included a decrease in the proportion of time spent
with oxygen saturation <90% from a mean of 14% to 1% (at
a mean airway pressure of 8.3 cm H2O) and a decrease in
mean transcutaneous carbon dioxide from 57 to 31 mm
Hg. All 7 infants were discharged home with the device,
which was used at home for an average of >8 hours per
day. No facial adverse effects were reported.35 There is anec-
dotal evidence, however, that long-term nasal continuous
positive airway pressure use in young children may result
in mid-face hypoplasia.36 Although particularly relevant to
patients with RS, who may have a hypoplastic maxilla any-
way,37 this potential adverse effect has not been studied
systematically.Poets and Bacher
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Tracheostomy clearly resolves UAO, but it does not correct
the underlying malformation and puts considerable burden
on the families, who often require additional nursing staff
and expensive supplies.38 It is also fraught with numerous
complications, including granuloma formation, which
occurs in most patients and requires intervention with gen-
eral anesthesia in 10% of cases,39 bleeding, pneumothorax,
tracheal stenosis, tube displacement, impaired speech devel-
opment, and even sudden death (the latter in 1%-4% of
cases).40 In a survey of parents of 41 pediatric patients with
RS who underwent tracheostomy, 60% of children required
$3 hospitalizations and 23% of children reported airway
problems after decannulation.41
Although the procedure should be reserved for severe
cases, the proportion of patients undergoing tracheostomy
is as high as 50% in some case series.38 Corresponding to
this, 52% of respondents in the aforementioned survey con-
sidered tracheostomy the treatment of choice in patients who
failed observation and positioning.8 This, however, is in con-
trast to other centers’ experience (see below).
Palatal Plates
These plates have been used in infants with RS since the late
1960s.42 Their effect is thought to be mediated via an
improved tongue function, with the latter stimulating man-
dibular growth, although data supporting this concept are
sparse.43,44
In a recent case series involving 188 infants with RS seen in
one center, a palatal plate was used in 134, resulting in a res-
olution of glossoptosis and, thereby, of clinically evident air-
way obstruction in 122 (91%).45 Feeding problems, however,Figure 1. Lateral and dorsal views of the PEBP. Reprinted with p
2010;89:621-7.
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plate therapy, and the extent of airway obstruction was not
assessed objectively nor were any data provided on weight
gain. Only 9% of the 188 patients, however, received invasive
treatments (tracheostomy, 2.1%; glossopexy, 6.9%), which is
considerably less than in other large case series.38
In infants with more severe UAO, a modified acrylic palatal
plate in which a velar extension resembling a spur or baton shifts
the base of the tongue forward may considerably improve the
UAO (Figures 1 and 2).46 The baton’s stability in this so-called
pre-epiglottic baton plate (PEBP) is increased by incorporating
a wire into the acrylic (Figure 1). The correct length and angle
of the baton are controlled endoscopically, and its effectiveness
in relieving UAO can be confirmed with PSG. Treatment
is supplemented by stimulation of the oral musculature,
on the basis of the Castillo-Morales approach47 and
feeding training (initially via finger feeding, subsequently
by a nurser which allows to control the ease of milk
flow during sucking [Playtex Drop-Ins, Playtex Products,
Neenah, Wisconsin]). The treatment aforementioned
requires an interdisciplinary team consisting of an
orthodontist, a pediatric sleep specialist, a speech therapist
familiar with orofacial regulation therapy, and a pediatrician
trained in nasopharyngeal endoscopy. An experienced
nursing team is also of paramount importance, especially
to train parents in handling the PEBP. Starting this
treatment as soon as possible after birth seems to reduce
the duration of PEBP treatment, because the mandible has
its largest growth potential early in life.44,46
In a randomized controlled crossover trial, the effective-
ness of the PEBP in relieving UAO was tested against a con-
ventional palatal plate, used as a sham procedure, in 11
infants <3 months old with isolated RS and a mixed-ermission from Bacher M et al, Laryngo-Rhino-Otologie
Robin-Like Phenotype 889
Figure 2. Lateral view of an infant with syndromal RS requiring a naso-pharyngeal airway for airway obstruction. The patient was
successfully transitioned to a PEBP, which was used for 3 years with no complications, and had cleft palate repair at 4 years of
age. The same patient is shown on the right at 6 years of age. Left panel reprinted from Bacher M. et al., Laryngo-Rhino-Otologie
2010;89:621-7, with permission. Photographs shown with parental permission.
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tion. After 48 hours of treatment, median MOAI had fallen
from 13.8 to 3.9 with the PEBP (P < .001), and it remained
unchanged with the sham procedure. In an uncontrolled lon-
gitudinal study involving 15 patients (median age at onset of
treatment, 5 days), median MOAI fell from 17.2 to 1.2 after 3
months of treatment with the PEBP. All infants had their
feeding tubes removed before hospital discharge and contin-
ued to gain weight at a mean rate of 24 g/day at discharge and
19 g/day at follow-up. All infants continued to be fully orally
fed at this time.46,48
Thus, the PEBP is the first intervention applied in RS the
effectiveness of which has been tested against a sham proce-
dure in a randomized study design and the long-term effects
of which have been shown to address both achievement of
appropriate weight gain (without a feeding tube) and resolu-
tion of significant UAO (MOAI <3). Variations of the PEBP
have been reported, but no studies documented their effect
with PSG.49,50 Because of the lack of comparative long-
term studies, it remains unclear whether effective treatmentTable. Treatment approaches used in RS
Approach









3. Correction of glossoptosis and functional induction of mandibular growth
Palatal plate
PEBP
890for milder forms of RS-related UAO can also be achieved
with a palatal plate without extension, as suggested by
B€utow’s data.45Cognitive Outcomes in Robin Sequence
Several authors suggested that RS is associated with impaired
cognition,10,51 but it is still unclear whether this is part of this
sequence or whether it results from the intermittent hypoxia
frequently associated with RS and should thus respond to
early treatment of UAO.
In a study of 34 children with non-syndromic RS who had
been treated with the PEBP during their first year of life and
were compared with a matched control group, cognition was
assessed by using the Kaufman Assessment Battery for Chil-
dren and a self-concept inventory.52 The cognitive develop-
ment of the children with RS, although poorer than that of
the healthy control subjects by an average of approximately
1 SD, was within the reference range for the inventory in
all children, and there was no significant difference compared
with control subjects in the distribution of the 3 categories
‘‘above average,’’ ‘‘average,’’ and ‘‘below average,’’ indicating
that these infants sustained some, but not substantial, cogni-
tive impairment.52 These results suggest that the considerable
cognitive impairment previously reported in many children
with isolated RS may not be directly related to RS, but may
rather be mediated via the recurrent hypoxia, sleep distur-
bance, or both resulting from UAO, which should be pre-
ventable with adequate and early treatment.
In conclusion, this review highlights the need to assess
any intervention used in RS with objective means (ie,
whether it results in adequate weight gain during bottle-
or breast-feeding and resolves UAO as documented with
PSG). Currently, only few treatments for RS appear toPoets and Bacher
December 2011 MEDICAL PROGRESSfulfill these criteria while not impeding facial growth. Be-
cause of the lack of clinical studies comparing one treat-
ment modality with another, treatment choices will have
to balance data from the studies aforementioned against
an institution’s experiences with the management strategy
used, the support it is able to offer, and the success rate of
the management strategy in the center’s hands. Further
data are necessary to assess the long-term effectiveness of
treatments for this rare, but potentially life-threatening
condition. n
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